Cao Xie

Title: Innovations by Inventor Cao Xie in Drug Delivery Systems

Introduction

Cao Xie is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical innovations. With a total of two patents to his name, Xie's work primarily focuses on advancing targeted diagnosis and treatment in oncology.

Latest Patents

Cao Xie's latest patents showcase his expertise in polypeptides and drug delivery systems. The first patent is for a VAP polypeptide and its use in preparing drugs for targeted diagnosis and treatment of tumors. This invention features highly stable D-configuration polypeptides, namely DVAP and SVAP, which demonstrate a high binding affinity to the GRP78 protein. The patent outlines the development of an L-configuration polypeptide LVAP, as well as DVAP or SVAP-modified model drugs and macromolecule carrier materials. These innovations are aimed at constructing tumor images and enhancing drug delivery systems for targeted cancer treatment.

His second patent details a method for preparing biofilm-coated drug nanocrystals. This innovative nano drug delivery system uses a drug in a nanocrystal form as a rigid supporting skeleton, which is then encapsulated in a biofilm. This approach provides a high drug loading capacity, ensures good biocompatibility, offers long systemic circulation times, and allows for sustained drug release.

Career Highlights

Cao Xie has worked with esteemed organizations such as the Shanghai Whittlong Pharmaceutical Institute and Fudan University. His experience in these institutions has played a vital role in shaping his research and inventions, contributing to advancements in drug formulation and delivery technologies.

Collaborations

Throughout his career, Cao has collaborated closely with notable colleagues, including Weiyue Lu and Zhilan Chai. These partnerships have facilitated the development of innovative solutions in the pharmaceutical field, enhancing the potential applications of his patented technologies.

Conclusion

Cao Xie's contributions to the fields of targeted tumor diagnostics and drug delivery systems underscore his role as a significant figure in pharmaceutical innovation. His patents reflect his commitment to advancing medical treatments, potentially improving outcomes for patients facing complex health challenges.